NDC 66621-0790

ANAVIP

Crotalidae Immune F(ab)2(equine)

ANAVIP is a Intravenous Injection, Powder, Lyophilized, For Solution in the Plasma Derivative category. It is labeled and distributed by Rare Disease Therapeutics, Inc. The primary component is Pit Viper (crotalinae) Immune Globulin Antivenin (equine).

• Product ID: 66621-0790_21a8934a-617c-4c84-aa88-4907ab40ccd2
• NDC: 66621-0790
• Product Type: Plasma Derivative
• Proprietary Name: ANAVIP
• Generic Name: Crotalidae Immune F(ab)2(equine)
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2015-05-06
• Marketing Category: BLA / BLA
• Application Number: BLA125488
• Labeler Name: Rare Disease Therapeutics, Inc
• Substance Name: PIT VIPER (CROTALINAE) IMMUNE GLOBULIN ANTIVENIN (EQUINE)
• Active Ingredient Strength: 24 mg/mL
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 66621-0790-2

1 VIAL in 1 CARTON (66621-0790-2) > 10 mL in 1 VIAL (66621-0790-1)

• Marketing Start Date: 2015-05-06
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 66621-0790-1 [66621079001]

ANAVIP INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

• Marketing Category: BLA
• Application Number: BLA125488
• Product Type: PLASMA DERIVATIVE
• Billing Unit: EA
• Marketing Start Date: 2015-05-06

NDC 66621-0790-2 [66621079002]

ANAVIP INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

• Marketing Category: BLA
• Application Number: BLA125488
• Product Type: PLASMA DERIVATIVE
• Billing Unit: EA
• Marketing Start Date: 2016-11-25

Drug Details

Active Ingredients

Ingredient	Strength
PIT VIPER (CROTALINAE) IMMUNE GLOBULIN ANTIVENIN (EQUINE)	24 mg/mL